Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer

被引：0

作者：

Lippman, Marc ^{[1
]}

机构：

[1] Georgetown Univ, Dept Oncol, Washington, DC 20057 USA

来源：

LANCET ONCOLOGY | 2019年 / 20卷 / 03期

关键词：

D O I：

10.1016/S1470-2045(18)30913-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：312 / 313

页数：2

共 6 条

[1] Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole [J].

Bundred, Nigel J. ;

Campbell, Ian D. ;

Davidson, Neville ;

DeBoer, Richard H. ;

Eidtmann, Holger ;

Monnier, Alain ;

Neven, Patrick ;

von Minckwitz, Gunter ;

Miller, Joel C. ;

Schenk, Nora L. ;

Coleman, Robert E. .

CANCER, 2008, 112 (05) :1001-1010

[2] Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials [J].

Coleman, R. ;

Powles, T. ;

Paterson, A. ;

Gnant, M. ;

Anderson, S. ;

Diel, I. ;

Gralow, J. ;

von Minckwitz, G. ;

Moebus, V. ;

Bergh, J. ;

Pritchard, K. I. ;

Bliss, J. ;

Cameron, D. ;

Evans, V. ;

Pan, H. ;

Peto, R. ;

Bradley, R. ;

Gray, R. ;

Bartsch, R. ;

Dubsky, P. ;

Fesl, C. ;

Fohler, H. ;

Greil, R. ;

Jakesz, R. ;

Lang, A. ;

Luschin-Ebengreuth, G. ;

Marth, C. ;

Mlineritsch, B. ;

Samonigg, H. ;

Singer, C. F. ;

Steger, G. G. ;

Stoeger, H. ;

Olivotto, I. ;

Ragaz, J. ;

Christiansen, P. ;

Ejlertsen, B. ;

Ewertz, M. ;

Jensen, M-B ;

Moller, S. ;

Mouridsen, H. T. ;

Eiermann, W. ;

Hilfrich, J. ;

Jonat, W. ;

Kaufmann, M. ;

Kreienberg, R. ;

Schumacher, M. ;

Blohmer, J. U. ;

Costa, S. D. ;

Eidtmann, H. ;

Gerber, B. .

LANCET, 2015, 386 (10001) :1353-1361

[3] Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial [J].

Gnant, Michael ;

Pfeiler, Georg ;

Steger, Guenther G. ;

Egle, Daniel ;

Greil, Richard ;

Fitzal, Florian ;

Wette, Viktor ;

Balic, Marija ;

Haslbauer, Ferdinand ;

Melbinger-Zeinitzer, Elisabeth ;

Bjelic-Radisic, Vesna ;

Jakesz, Raimund ;

Marth, Christian ;

Sevelda, Paul ;

Mlineritsch, Brigitte ;

Exner, Ruth ;

Fesl, Christian ;

Frantal, Sophie ;

Singer, Christian F. .

LANCET ONCOLOGY, 2019, 20 (03) :339-351

[4] Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial [J].

Gnant, Michael ;

Pfeiler, Georg ;

Dubsky, Peter C. ;

Hubalek, Michael ;

Greil, Richard ;

Jakesz, Raimund ;

Wette, Viktor ;

Balic, Marija ;

Haslbauer, Ferdinand ;

Melbinger, Elisabeth ;

Bjelic-Radisic, Vesna ;

Artner-Matuschek, Silvia ;

Fitzal, Florian ;

Marth, Christian ;

Sevelda, Paul ;

Mlineritsch, Brigitte ;

Steger, Guenther G. ;

Manfreda, Diether ;

Exner, Ruth ;

Egle, Daniel ;

Bergh, Jonas ;

Kainberger, Franz ;

Talbot, Susan ;

Warner, Douglas ;

Fesl, Christian ;

Singer, Christian F. .

LANCET, 2015, 386 (9992) :433-443

[5] Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update Summary [J].

Van Poznak, Catherine ;

Somerfield, Mark R. ;

Moy, Beverly .

JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (12) :822-+

[6] Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues [J].

Vincent-Salomon, A. ;

Bidard, F. C. ;

Pierga, J. Y. .

JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (05) :570-576

← 1 →